Skip to main content
. 2020 Dec 14;10:21853. doi: 10.1038/s41598-020-78864-4

Figure 3.

Figure 3

PGE2 secretion is elevated in hMSC-IL6i cells. (A) Secretion of PGE2 into cell culture supernatants of hMSC-emp or hMSC-IL6i, treated or not (NT) with indomethacin (INDO) or etoricoxib (ETO) (5 μM), measured by ELISA. (B) Quantification of COX2 mRNA by real time qPCR in hMSC-emp or hMSC-IL6i cells. Data are shown as mean ± SD from three independent experiments. (C) Proliferation of T-cells cultured in the absence of hMSCs (w/o) or co-cultured with hMSC-emp or hMSC-IL6i cells, in presence or absence (NT) of indomethacin (INDO) and etoricoxib (ETO). Data are shown as mean ± SD from three independent experiments.